ReviewDrug design, development and therapy2017
Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy.
Audrey Bellesoeur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it